×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Eisai Completes FDA Submission for LEQEMBI® IQLIK™ Subcutaneous Starting Dose.
HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline
26 Jan 2026
HanchorBio, Inc. a global clinical-stage biotechnology company advancing next-generation
...
IKA introduces new accessories for the HABITAT research bioreactor.
Children’s Hospital Los Angeles completes its 100th retinal gene therapy procedure, advancing pediatric vision care.
AbbVie submits FDA application for SKYRIZI® (risankizumab-rzaa) subcutaneous induction in adults with moderate to severe Crohn’s disease
Why the Pharmacy System Rewards the Wrong Results: It Is Working as Designed
CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
By
CaseBioscience
CaseBioscience
02 Oct 2026
Ensera Launched Alliance Network with SHL Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectables.
By
Ensera
Ensera
02 Oct 2026
Niagen Bioscience Puts 25 Years of NAD+ Science Behind “Don’t Get Old. Age Better.®” — a New Campaign for Its Niagen® Brand Featuring Legendary Surfer Kelly Slater
By
Niagen Bioscience, Inc
Niagen Bioscience, Inc
02 Oct 2026
Upsher-Smith Launched Fluvoxamine Maleate Extended-Release Capsules
By
Upsher-Smith Laboratories, LLC
Upsher-Smith Laboratories, LLC
01 Oct 2026
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs
By
Cronus Pharma LLC
Cronus Pharma LLC
01 Oct 2026
Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership
By
Packaging Compliance Labs
Packaging Compliance Labs
30 Sep 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
GoodRx debuts a new e-commerce platform, starting with Opill®
By
GoodRx
Oct 31
Galvanize Therapeutics receives FDA clearance for the Aliya EX Generator, expanding its Aliya Pulsed Electric Field portfolio
By
Galvanize Therapeutics, Inc.
May 18
Rugiet Launched Physician-Prescribed Peptide and Longevity Therapies, Setting a New Standard in Performance Medicine
By
Rugiet
Jun 17
October
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand